Daniel Fanaras

Mr. Fanaras has more than two decades of experience providing economic analyses for matters before courts, in arbitrations, and in regulatory proceedings. His work focuses on antitrust and competition issues, damages, and economic issues arising in class certification for both plaintiffs and defendants.

Mr. Fanaras has more than two decades of experience providing economic analyses for matters before courts, in arbitrations, and in regulatory proceedings. His work focuses on antitrust and competition issues, damages, and economic issues arising in class certification for both plaintiffs and defendants.

His antitrust experience includes evaluating the competitive effects of mergers and assessing liability and damages arising from allegations of anticompetitive conduct. In the healthcare space, he leads Brattle’s Healthcare & Life Sciences practice and specializes in analyzing competition in the US health insurance industry. His experience also includes analyzing the competitive effects of hospital mergers and restrictive practices, as well as addressing liability and damages arising in medical reimbursement disputes. In addition, Mr. Fanaras managed Brattle’s expert work in the In Re Blue Cross Blue Shield Antitrust MDL litigation on behalf of the subscriber class plaintiffs.

Across matters, Mr. Fanaras has analyzed economic issues in dozens of industries, including air transportation, wireless telecommunications, financial services, and agriculture. A significant component of his work involves collaborating closely with academic experts in industrial organization and econometrics in connection with expert testimony. His work also includes developing and managing empirical analyses involving large and complex datasets, and he advises clients on the discovery of structured data in litigation and merger investigations.